A comparison of medroxyprogesterone serum concentrations by the oral or intramuscular route in patients with persistent or recurrent endometrial carcinoma
- 1 November 1979
- journal article
- clinical trial
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 135 (5), 647-650
- https://doi.org/10.1016/s0002-9378(16)32990-8
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Measurement of Medroxyprogesterone Acetate (Provera) by Radioimmunoassay1Journal of Clinical Endocrinology & Metabolism, 1971
- Management of advanced endometrial adenocarcinoma with medroxyprogesterone acetateAmerican Journal of Obstetrics and Gynecology, 1965
- Effect of a Progestational Agent on Endometrial Hyperplasia and Endometrial CancerObstetrics & Gynecology, 1964
- Progestational Agents in the Treatment of Carcinoma of the EndometriumNew England Journal of Medicine, 1961
- Histological effects of progestins on hyperplasia and carcinoma in situ of the endometriumCancer, 1959